Editorial : Translational research and drug repurposing for non-communicable diseases (NCDs)

dc.contributor.authorAkindele, Abidemi J.
dc.contributor.authorFatokun, Amos A.
dc.contributor.authorUzochukwu, Ikemefuna C.
dc.contributor.authorSteenkamp, Vanessa
dc.contributor.authorAgyare, Christian
dc.contributor.authorFamiloni, Oluwole
dc.contributor.authorJames, Margaret O.
dc.date.accessioned2022-07-29T05:34:07Z
dc.date.available2022-07-29T05:34:07Z
dc.date.issued2022-03-21
dc.description.abstractNo abstract available.en_US
dc.description.departmentPharmacologyen_US
dc.description.librariandm2022en_US
dc.description.urihttps://www.frontiersin.org/journals/pharmacologyen_US
dc.identifier.citationAkindele, A.J., Fatokun, A.A., Uzochukwu, I.C., Steenkamp, V., Agyare, C., Familoni, O. & James, M.O. (2022) Editorial: Translational Research and Drug Repurposing for NonCommunicable Diseases (NCDs). Frontiers in Pharmacology 13:879611. doi: 10.3389/fphar.2022.879611.en_US
dc.identifier.issn1663-9812 (online)
dc.identifier.other10.3389/fphar.2022.879611
dc.identifier.urihttps://repository.up.ac.za/handle/2263/86575
dc.language.isoenen_US
dc.publisherFrontiers Media S.A.en_US
dc.rights© 2022 Akindele, Fatokun, Uzochukwu, Steenkamp, Agyare, Familoni and James. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY).en_US
dc.subjectDrug repositioningen_US
dc.subjectCanceren_US
dc.subjectCardiovascular disease (CVD)en_US
dc.subjectDiabetesen_US
dc.subjectNeurodegenerative diseasesen_US
dc.subjectNon-communicable diseases (NCDs)
dc.subjectEditorial
dc.titleEditorial : Translational research and drug repurposing for non-communicable diseases (NCDs)en_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Akindele_Editorial_2022.pdf
Size:
527.67 KB
Format:
Adobe Portable Document Format
Description:
Article

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.75 KB
Format:
Item-specific license agreed upon to submission
Description: